General Manager · IBEG — Erasto Gaertner Bioengineering Institute
I turn technology into a product that can be sold, manufactured and cleared by regulators. Twenty years between R&D and the factory floor — healthtech, consumer goods and heavy industry — with results measured in P&L, not in papers.
Where I built it
US$ 25M
saved in global platform modularization
Electrolux
BRL 7M/yr
in production losses eliminated — Cpk from 0.15 to 1.63
Dexco (Duratex)
25 people
and 9 areas under direct management, with full P&L ownership
IBEG
8 patents
filed with the Brazilian PTO between 2012 and 2024, plus one registered trademark
Additive manufacturing & AI
Where I create value
Engineering that ships: hardware, software, firmware, AI and UX under one roadmap, one product file and one release cadence — from proof of concept to a manufacturable, certifiable product.
Infant.ID · Zirconium · Concep3D
Scrap, rework and process capability attacked with data and with the line running. Recurring loss becomes margin, and the gain holds after I leave.
Dexco · Electrolux · Altran
Medical devices, regulatory affairs, IP governance, PLM and quality management built so that innovation survives audit — and so that the company can sell abroad.
IBEG · Infant.ID · Senzo Health
Track record
US$ 25M
Redesign of the product architecture into shared modules across the global portfolio, cutting part count, tooling and development cost.
Electrolux · 2010–2015
BRL 7M/yr
Process capability lifted from Cpk 0.15 to 1.63 on the critical line, turning recurring scrap into recovered margin.
Dexco (Duratex) · 2017–2018
NPS 23 → 52
SUS score up from 43 to 77 alongside NPS, after a full review of hardware, software and service journey.
Infant.ID · 2026
−83%
From 42 to 7 tickets a month, by fixing the root causes in engineering instead of scaling the support team.
Infant.ID · 2026
2 → 11
Modular product line plus a systems overhaul (PLM, CRM, project management) that cut roughly BRL 820k a year in systems cost.
Infant.ID · 2026
9 areas
Product, systems, industrial, regulatory, commercial, finance, research, quality assurance and technical pre-sales — 25 professionals, one governance model.
IBEG · 2026–
Career
2026 — present
IBEG — Erasto Gaertner Bioengineering Institute · Curitiba, Brazil
End-to-end responsibility for P&L, product, industrial operation and regulatory affairs across nine areas and 25 professionals. Rolling out corporate PLM, CRM and portfolio governance.
2026
Infant.ID · neonatal identification healthtech
Product, engineering, IP governance and customer experience. NPS 23→52, tickets down 83%, line modularized from 2 to 11 products.
2020 — 2026
Zirconium · deep tech in additive manufacturing
From fundraising to deep tech product development and international homologation in Europe and Asia. Two invention patents filed in the period.
2024 — present · part-time
Instituto Zirconium · science and technology institute (ICT)
Research portfolio, partnerships with universities and research institutes, funding and IP governance.
2017 — 2018
Dexco (Duratex) · Hydra Corona division
BRL 7 million a year in production losses eliminated; process capability from Cpk 0.15 to 1.63.
2013 — 2020
Concep3D · two periods (2013–2017 and 2018–2020)
Product development and additive manufacturing projects for industrial clients, including five patents drafted on their behalf.
2010 — 2015
Electrolux
US$ 25 million saved through global platform modularization across the product portfolio.
2007 — 2010
Altran · ZM S.A.
Start of the career in automotive and capital goods engineering, between design, manufacturing and cost reduction.
Foundations
Sectors
Contact
I speak with headhunters, boards and companies about product, industrial operations and technology in regulated environments. Every conversation is treated as confidential.